Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

Global Market Issues
Administrative and Public Law
Aerospace and Defense
Antitrust and Competition
Automotive and Mobility
Banking and Loan Finance
Business and Human Rights
Capital Markets
Construction and Engineering
Consumer
Corporate Governance / Public Company Advisory / Company Law
Data, Privacy and Cybersecurity
Education
Employment
Energy and Natural Resources
Environment
Esports and Gaming
Executive Compensation, Employee Benefits and Share Incentives
Financial Services
Food and Beverage
Gaming and Gambling Law
Government Contracts and Public Procurement
Government Relations
Health Regulatory
Infrastructure, Energy, Resources and Projects
Insurance / re-insurance
Intellectual Property
International Arbitration
International Trade and Investment
Investigations, White Collar and Fraud
Leveraged and Acquisition Finance
Life Sciences and Health Care
Manufacturing and Industrials
Media and Entertainment
Medical Device and Technology Regulatory
Mergers and Acquisitions
Pensions
Pharmaceuticals and Biotechnology Regulatory
Private Capital
Private Equity, Venture Capital and Investment Funds
Products Law
Real Estate
REITs
Restructuring and Special Situations
Risks, Disputes, and Litigation
Space and Satellite
Sports
Strategic Operations, Agreements and Regulation
Sustainable Finance
Tax
Technology
Telecommunications and Internet
Transfer Pricing
Transportation and Logistics
Artificial Intelligence
Brexit
COVID-19
Digital Transformation
Digital Services Act and Digital Markets Act
ESG, Sustainability, and Climate
EU Green Deal
Federal Trade Commission (FTC)
Foreign Direct Investment
Inflation Reduction Act
Russia sanctions
Supply Chain
UK2030
Commercial Human Rights
Constitutional Law
Freedom of Information
Judicial Review
Public Law
Competition Litigation and Disputes
Derivatives and Structured Products
Equity Capital Markets
General Debt Capital Markets
High Yield
Securitization and Structured Finance
Trust and Agency
E-Commerce
Electronics and Consumer Appliances
Retail and Fashion
Energy Transition
Hydrogen
Mining
Nuclear
Oil, Gas and LNG
Power, renewables and alternative energy
Environmental Compliance, Litigation and Internal Investigations
Banking Products
Consumer Finance
Digital Assets and Blockchain
Financial Crime including Anti-money Laundering
Financial Services Litigation and Disputes
Financial Services Privacy
Financial Services Regulatory Investigations and Enforcement
Financial Services Securities and Markets Regulation
FinTech
Funds and Asset Management
Open Banking
Payments
Prudential Regulation
Gaming and Gambling Related Payments Services
Online Gaming and Gambling
Congressional Oversight and Investigation
Devolution and devolved administrations
Federal Funding and Appropriations
Legislation and Policy Engagement and Development
Political Law Compliance
Public Policy and Regulation
Sovereign Government Relations and Public Affairs
State,Local Government Representation and Policy
UK Parliamentary Affairs
Coverage and Reimbursement
Drug Pricing and Government Reporting
Health Compliance, Fraud and Abuse
Health Insurance Plans and Managed Care
Health Policy and Advocacy
Health Privacy
Copyright
Designs
Domain Names
IP and Technology Transactions
Patents
Trademarks and Brands
Trade Secrets and Confidential Know-how
Unfair Competition
Bribery and Corruption
False Claims Act
Financial Crime
Investigations, Regulatory and Compliance
Whistleblowing
Cell, Tissue, and Gene Therapies (CTGT)
Clinical Trials
Combination Products
Digital Health
Emerging Companies and Investors
Hospitals and Health Care Providers
Licensing and Commercial Transactions
Life Science Government Enforcement and Compliance
Chemicals and Industrial Products and Services
Conglomerates
Advertising and Promotion of Medical Devices
Clinical Studies Product Design and Development
Conformity Assessment Procedure,CE Mark
In Vitro Diagnostics
Joint Ventures and Strategic Alliances
MDR,IVDR
Medical Device Software and Cybersecurity
Postmarket Performance
Premarket Strategy, Submissions, and Review
Regulatory Inspections and QSR-ISO 13485
State Licensing of Medical Device
Joint Ventures and Strategic Alliances
Advertising and Promotion of Pharmaceuticals and Biotechnology
Biologics and Biosimilars
Controlled Substances
Life Cycle Management of Pharmaceuticals and Biotechnology
OTC Drugs and Cosmetics
Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes
Regulatory Inspections and cGMP
Fund Formation, Fund Raising, Restructuring and Dissolution
Infrastructure and Energy Funds
Investments, Financing, Portfolio Company Advice and Exits
Pension Funds
Private Capital Regulatory, Compliance and Disputes
Private Credit-Debt Funds
Private Equity Funds
Real Estate Investment Vehicles and Funds
Sovereign Wealth Funds
Venture Capital Funds
Fund Formation, Fund Raising, Restructuring and Dissolution
Management Incentive Programs
Private Equity Transactions
Secondaries
Venture Capital Transactions
Cross-border Real Estate
Development, Planning and Land Use
ESG in Real Estate
Hotels and Leisure
Real Estate Investment Vehicles and Funds
Real Estate Disputes
Real Estate Finance
Business Restructuring and Insolvency Litigation
Class Actions and Group Actions
Competition Litigation and Disputes
Corporate and Securities Litigation
Crisis Management
Financial Services Litigation and Disputes
Global Asset Recovery and Enforcement
Real Estate Disputes
Sovereign Asset Recovery
Technology Litigation and Disputes
U.S. Appellate and Supreme Court Litigation
Commercial Law and Contracts
Logistics
Mobility
Rail
Shipping
Uncrewed Aircraft Systems-Advanced Air Mobility-Drone Security

English
中文
Deutsch
Español
Français
日本語
Português

News

Pharmacy compounding under the EU pharma law package

01 August 2025

Insights and Analysis

EFRAG launch consultation on simplified European Sustainability Reporting Standards (ESRS) under the Corporate Sustainability Reporting Directive (CSRD)

01 August 2025

News

CJEU’s AG on EU designs: Designs do not require originality, and fashion trends do not limit the freedom of the designer

01 August 2025

Insights and Analysis

Unblocking the housing pipeline in the UK

01 August 2025

News

HRSA issues notice regarding 340B Rebate Model Pilot Program, limited to drugs subject to a maximum fair price (MFP) for 2026

01 August 2025

Insights and Analysis

Securing supply in disruptive times – Ways to set up and adapt strategic sourcing agreements

31 July 2025

News

Ancillary activities exemption: FCA Consultation Paper 25/19

31 July 2025

News

Employment in the news | July 2025

31 July 2025

News

SEC staff updates guidance on Section 13 beneficial ownership reporting rules

31 July 2025

News

EPA proposes reconsidering the 2009 GHG endangerment finding

31 July 2025

Insights and Analysis

Turnaround of Medical Cannabis in Germany? – Draft bill by new German Government to address alleged missteps

31 July 2025

News

SBIC Program updates: SBA proposes regulatory amendments related to SBIC Program

30 July 2025

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Our thinking

News

Insights and Analysis

News

Insights and Analysis

News

Insights and Analysis

News

News

News

News

Insights and Analysis

News

No results found